Causes of Death of Patients With Lung Cancer

被引:116
作者
Nichols, Larry [1 ]
Saunders, Rachel [1 ]
Knollmann, Friedrich D. [2 ]
机构
[1] Univ Pittsburgh, Presbyterian Hosp, Med Ctr, Dept Pathol, Pittsburgh, PA 15213 USA
[2] Univ Pittsburgh, Presbyterian Hosp, Med Ctr, Dept Radiol, Pittsburgh, PA 15213 USA
关键词
PROGNOSTIC-FACTOR; TUMOR VOLUME; SURVIVAL; PREDICTOR; RESECTION;
D O I
10.5858/arpa.2011-0521-OA
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Context.-The causes of death for patients with lung cancer are inadequately described. Objective.-To categorize the immediate and contributing causes of death for patients with lung cancer. Design.-The autopsies from 100 patients who died of lung cancer between 1990 and February 2011 were analyzed. Results.-Tumor burden was judged the immediate cause of death in 30 cases, including 26 cases of extensive metastases and 4 cases with wholly or primarily lung tumor burden (causing respiratory failure). Infection was the immediate cause of death for 20 patients, including 8 with sepsis and 12 with pneumonia. Complications of metastatic disease were the immediate causes of death in 18 cases, including 6 cases of hemopericardium from pericardial metastases, 3 from myocardial metastases, 3 from liver metastases, and 3 from brain metastases. Other immediate causes of death were pulmonary hemorrhage (12 cases), pulmonary embolism (10 cases, 2 tumor emboli), and pulmonary diffuse alveolar damage (7 cases). From a functional (pathophysiologic) perspective, respiratory failure could be regarded as the immediate cause of death (or mechanism of death) in 38 cases, usually because of a combination of lung conditions, including emphysema, airway obstruction, pneumonia, hemorrhage, embolism, resection, and lung injury in addition to the tumor. For 94 of the 100 patients, there were contributing causes of death, with an average of 2.5 contributing causes and up to 6 contributing causes of death. Conclusions.-The numerous and complex ways lung cancer kills patients pose a challenge for efforts to extend and improve their lives. (Arch Pathol Lab Med. 2012; 136: 1552-1557; doi: 10.5858/arpa.2011-0521-OA)
引用
收藏
页码:1552 / 1557
页数:6
相关论文
共 27 条
[1]   TUMOR VOLUME IS A PROGNOSTIC FACTOR IN NON-SMALL-CELL LUNG CANCER TREATED WITH CHEMORADIOTHERAPY [J].
Alexander, Brian M. ;
Othus, Megan ;
Caglar, Hale B. ;
Allen, Aaron M. .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2011, 79 (05) :1381-1387
[2]   Metastatic tumor of the heart: description of a case [J].
Baratella, Maria C. ;
Calamelli, Sara ;
D'Este, Daniele .
JOURNAL OF CARDIOVASCULAR MEDICINE, 2011, 12 (10) :741-742
[3]   Gross tumor volume, critical prognostic factor in patients treated with three-dimensional conformal radiation therapy for non-small-cell lung carcinoma [J].
Bradley, JD ;
Ieumwananonthachai, N ;
Purdy, JA ;
Wasserman, TH ;
Lockett, MA ;
Graham, MV ;
Perez, CA .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2002, 52 (01) :49-57
[4]   Quality of life assessment as a predictor of survival in non-small cell lung cancer [J].
Braun, Donald P. ;
Gupta, Digant ;
Staren, Edgar D. .
BMC CANCER, 2011, 11
[5]  
Brown T., 2008, NY TIMES, pF1
[6]   Prognostic factors in non-small cell lung cancer - A decade of progress [J].
Brundage, MD ;
Davies, D ;
Mackillop, WJ .
CHEST, 2002, 122 (03) :1037-1057
[7]   Bronchoscopy for bevacizumab-related hemoptysis [J].
Cho, Young-Jae ;
Murgu, Septimiu D. ;
Colt, Henri G. .
LUNG CANCER, 2007, 56 (03) :465-468
[8]   Pulmonary Toxicity Related to Systemic Treatment of Nonsmall Cell Lung Cancer [J].
De Sanctis, Alice ;
Taillade, Laurent ;
Vignot, Stephane ;
Novello, Silvia ;
Conforti, Rosa ;
Spano, Jean Philippe ;
Scagliotti, Giorgio Vittorio ;
Khayat, David .
CANCER, 2011, 117 (14) :3069-3080
[9]  
Gajra Ajeet, 2011, Hosp Pract (1995), V39, P107, DOI 10.3810/hp.2011.04.400
[10]   Comorbidity in Lung Cancer: Important but Neglected. A Review of the Current Literature [J].
Grose, Derek ;
Devereux, Graham ;
Milroy, R. .
CLINICAL LUNG CANCER, 2011, 12 (04) :207-211